All News

EULAR19.abstract.jpg (keep)

Featured Abstracts from Industry at EULAR 2021

Jack Cush, MD

Many great presentations this week at EULAR 2021 will feature industry sponsored clinical trials and reports.  Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.

Read Article
COVID.Flu_.Virus_.jpg (keep)

Factors Associated with COVID-19 Deaths in Rheumatic Patients

Jack Cush, MD

Analysis of data from the COVID-19 Global Rheumatology Alliance shows that rheumatic diseases infected with COVID-19 had a greater risk of death with age, comorbidities, high disease activity and few specific therapies.

Read Article
RheumNow Podcast square

RheumNow Podcast – Myth Busters (5.21.2021)

Jack Cush, MD

Dr Jack Cush reviews the news and journal reports from the past week on RheumNow.com

Read Article
Malar,rash,SLE, Lupus

Anifrolumab Reduces Lupus Flares

Jack Cush, MD

Anifrolumab has been studied in two large phase 3 trials in systemic lupus erythematosus (SLE) patients; pooled data from both the TULIP-1 and TULIP-2 trials were used to show that anifrolumab reduces flares in patients with moderate to severe SLE. 

Read Article
RheumNow Podcast square

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!

Read Article
RNL, over, microphone

RheumNow Live 2021 Now Available for All

Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
Hands-Down Rheumatology - Sarcoidosis usually presents as a monarthritis or oligoarthritis. Late sarcoid arthritis affects knees, ankles, fingers (dactylitis). Bony lesions show honeycomb trabecular pattern). https://t.co/lmXBbJz6ts

Links:

Dr. John Cush RheumNow ( View Tweet)

Top May Tweet: Belimumab now approved in the EU for lupus nephritis. The EMA has approved intravenous and subcutaneous Benlysta (belimumab) in combination with background immunosuppressive therapies for adults with active lupus nephritis https://t.co/Twbe1ClT5w

Links:

Dr. John Cush RheumNow ( View Tweet)

News: Factors Associated with COVID-19 Deaths in Rheumatic Patients https://t.co/FzsINtpZEz https://t.co/QzuLZRKaZy

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Mike Putman - TULIP Trials - Anifrolumab in SLE https://t.co/cqZiulDMFm https://t.co/Vo17RfBOSk

Links:

Dr. John Cush RheumNow ( View Tweet)
Cohort analysis of 251 SLE patients with and without new-onset arrhythmia (taken from 2499 incident SLE Taiwan claims data). Plaquenil use showed no increased risk of arrhythmia (adj OR = 1.49; 0.98-2.25) or ventricular arrhythmia (adjOR =1.02). https://t.co/vkTi3X7hiM

Links:

Dr. John Cush RheumNow ( View Tweet)

If any rheums out there have not watched the vaccine town hall by @ACRheum I highly recommend it. A master class on vaccine counseling by @gradydoctor ! Thank you! Thanks @IreneBlancoMD and @DrDavidKarp https://t.co/4ofQVkjKYz via @YouTube

Links:

Jilaine Bolek Berquist BolekBerqui ( View Tweet)

Textbooks say fever is common in lupus ("36%–86%") BUT IT IS NOT! Lupus is cause of FUO in 5%; Fever is seen in a minority of SLE onsets; Fever occurs w/ SLE complications - vasculitis, pneumonitis/serositis/alveolar hem, CNS, & INFECTION! https://t.co/KvZeo6Q1WY

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Jack Cush - Hemoptysis in Lupus https://t.co/SjBazKiTW8 #LupusAwarenessMonth https://t.co/6z2R456Clm

Links:

Dr. John Cush RheumNow ( View Tweet)
International survey by the World Lupus Federation of 6,100 lupus pts from over 85 countries shows 50% reporting decreased access to lupus healthcare; including /rheumatologist 36%, medical tests 29%, infusions 24%, meds 17% https://t.co/5tlbiP65gf

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i #LupusAwarenessMonth https://t.co/apjrwa36dA

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Mike Putman - TULIP Trials - Anifrolumab in SLE https://t.co/cqZiulDMFm #LupusAwarenessMonth https://t.co/kNKLUSOKWp

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i https://t.co/CRqUKeYUmi

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Kathryn Dao - Lupus Pearls from ACR 2019 https://t.co/JDlfjAO0xe #LupusAwarenessMonth https://t.co/1ZiZiNvYhv

Links:

Dr. John Cush RheumNow ( View Tweet)
It's #LupusAwarenessMonth --review our lupus coverage from the archives. Dr. Janet Pope - New SLE criteria and guidelines and approach to refractory Lupus patients From RWCS 2020 https://t.co/eufxObGFic https://t.co/pReB8aPHlp

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×